LINC01432 binds to CELF2 in newly diagnosed multiple myeloma promoting short progression-free survival to standard therapy
R. Mishra, P. Thunuguntla, A. Perkin, D. Duraiyan, K. Bagwill, S. Gonzales, V. Brizuela, S. Daly, Y. J. Chang, M. Abebe, Y. Rajana, K. Wichmann, C. Bolick, J. King, M. Fiala, , J. Silva-Fisher
This study identifies LINC01432 as a lncRNA that binds to CELF2 and inhibits apoptosis in multiple myeloma, contributing to short progression-free survival to standard therapy.
bioRxiv · Jun 27, 2024 · PreprintCancer Biology